mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.12 |
0.06 |
mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.07 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.1 |
0.07 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.07 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.07 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |